Lilly Rises on FDA Approval of Weight-Loss Drug-Zepbound for Sleep Apnea

Key TakeawaysEli Lilly's Zepbound has been approved by the Food and Drug Administration (FDA) as a treatment for adults with sleep apnea and obesity, the drugmaker said after the bell Friday.Trials of the Lilly drug found that it helped reduce the number of breathing disruptions in an average night of sleep.Over a year, 50% of patients in one trial reported that their sleep apnea symptoms went away. Eli Lilly's (LLY) Zepbound has received Food and Drug Administration (FDA) approval as a treatment for obstru ...